MedPath

Effects of One-to-one Service on the Continuation and Satisfaction of Contraceptive Use.

Not Applicable
Conditions
Contraceptive Usage
Contraception Behavior
Interventions
Other: Family Planning Service
Other: One-to-one Service
Registration Number
NCT05362019
Lead Sponsor
National Research Institute for Family Planning, China
Brief Summary

This study aims to explore the impact of a mobile based one-to-one service model on improving the continuation and satisfaction of combined injectable contraceptive use, and improve the utilization and acceptability of efficient and long-term contraceptive methods.

Detailed Description

In China, due to the lack of understanding or misunderstanding of hormonal contraception by service providers and the public, the use of combined injectable contraceptive is not common. Therefore, this study aims to explore the impact of a mobile based one-to-one service model on improving the continuation and satisfaction of combined injectable contraceptive use, and improve the utilization and acceptability of efficient and long-term contraceptive methods.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
400
Inclusion Criteria
  • 18 to 40 years old;
  • Healthy Volunteers;
  • More than 6 months after delivery and without lactation;
  • No fertility intention within 6 months;
  • Normal menstruation;
  • No contraindications to the use of compound contraceptive methods;
  • Had not used hormonal contraception in the previous three months;
  • Understand the content and requirements of the project, be willing to cooperate, and have signed the informed consent form;
  • Have a certian education level, and be able to use the special sanitary napkins to record menstrual volume and menstrual card.
Exclusion Criteria
  • Suffering from serious systemic diseases;
  • Previous or current thrombotic disease;
  • Malignant tumor of uterine organ;
  • Unable to communicate normally due to disability or mental or intellectual impairment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
intervention groupCompound Norethisterone Enanthate InjectionA mobile phone based "service system" developed by the research group will be used to provide one-to-one service for the intervention group.
control groupFamily Planning ServiceRoutine family planning services will be provided to the control group.
control groupCompound Norethisterone Enanthate InjectionRoutine family planning services will be provided to the control group.
intervention groupOne-to-one ServiceA mobile phone based "service system" developed by the research group will be used to provide one-to-one service for the intervention group.
Primary Outcome Measures
NameTimeMethod
Termination rate6 months

The termination rates of the two groups were observed for 6 months.

Continuation rate6 months

The continuation rates of the two groups were observed for 6 months.

Satisfaction ratesUp to 4 weeks

The satisfaction rates of two groups after a 6 months of contraceptive use.

Secondary Outcome Measures
NameTimeMethod
Complaint of adverse reactionsUp to 9 months

Complaint rates of various adverse reactions (dizziness / breast swelling / nausea) during different follow-up time.

Vaginal bleeding patternUp to 9 months

Collecting the vaginal bleeding patterns (including menstrual onset time, duration, and termination time) in two phases (90 days in each phase) and amount of menstrual bleeding at 3 months of use by using a self-developed questionnarie and special sanitary pads for measurement.

DysmenorrheaUp to 9 months

Dysmenorrhea will be collacted by a self-developed questionnarie (on a 10-point scale). A higher score indicated higher level of pain.

Waist and abdomen pain related to gynecologyUp to 9 months

The pain will be collacted by a self-developed questionnarie (on a 10-point scale). A higher score indicated higher level of pain.

Sexual intercourse painUp to 9 months

The pain will be collacted by a self-developed questionnarie (on a 10-point scale). A higher score indicated higher level of pain.

Trial Locations

Locations (8)

Qinghai Red Cross Hospital

🇨🇳

Xining, Qinghai, China

Tianjin Central Hospital of Gynecology Obstetrics

🇨🇳

Tianjin, Tianjin, China

Yunnan Xishuangbanna people's Hospital

🇨🇳

Xishuangbanna, Yunnan, China

Tianjin Jinnan hospital

🇨🇳

Tianjin, Tianjin, China

Yunnan Xishuangbanna maternal and Child Health Hospital

🇨🇳

Xishuangbanna, Yunnan, China

Qinghai People's Hospital

🇨🇳

Xining, Qinghai, China

Tianjin Dongli hospital

🇨🇳

Tianjin, Tianjin, China

Tianjin Medical University second hospital

🇨🇳

Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath